Advanced search
Publication Cover
Platelets Volume 25, 2014 - Issue 7
Submit an article Journal homepage
3,230
Views
120
CrossRef citations to date
0
Altmetric
Research Article

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

Robert F. StoreyDepartment of Cardiovascular Science, University of Sheffield SheffieldUKCorrespondence[email protected]
,
Stefan K. JamesDepartment of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University UppsalaSweden
,
Agneta SiegbahnDepartment of Medical Sciences, Clinical Chemistry and Uppsala Clinical Research Center, Uppsala University UppsalaSweden
,
Christoph VarenhorstDepartment of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University UppsalaSweden
,
Claes HeldDepartment of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University UppsalaSweden
,
Joseph YcasAstraZeneca WilmingtonUSA
,
Steen E. HustedÅrhus University Hospital ÅrhusDenmark
,
Christopher P. CannonTIMI Study Group, Brigham and Women’s Hospital Boston, MAUSA
,
Richard C. BeckerDivision of Cardiovascular Health and Disease, and Heart, Lung and Vascular Institute, University of Cincinnati College of MedicineUSA
,
Ph Gabriel StegHopital Bichat, Assistance Publique-Höpitaux de Paris, and Departement Hospitalo Universitaire FIRE, Université Paris Diderot ParisFrance
,
Nils ÅsenbladDepartment of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University UppsalaSweden
&
Lars WallentinDepartment of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University UppsalaSweden
 show all
Pages 517-525 | Received 05 Sep 2013, Accepted 06 Sep 2013, Published online: 15 Oct 2013

Related Research Data

A systematic review on more than 34,000 subjects
Source: Georg Thieme Verlag KG
Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome.
Source: Springer
Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study
Source: Elsevier BV
Platelet and leukocyte activation correlate with the severity of septic organ dysfunction.
Source: Ovid Technologies (Wolters Kluwer Health)
Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes: The PLATO (PLATelet inhibition and patient Outcomes) PLATELET Substudy
Source: Elsevier BV
Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (A GUSTO IV substudy)
Source: Elsevier BV
Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model
Source: Ovid Technologies (Wolters Kluwer Health)
CONSISTENT BENEFIT OF TICAGRELOR COMPARED TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME PATIENTS REGARDLESS OF BASELINE INFLAMMATORY MARKERS
Source: American College of Cardiology Foundation. Published by Elsevier Inc.
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy.
Source: Elsevier BV
Adenosine receptors as therapeutic targets
Source: Springer Science and Business Media LLC
Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel
Source: HAL CCSD
Ticagrelor Does Not Inhibit Adenosine Transport at Relevant Concentrations: A Randomized Cross-Over Study in Healthy Subjects In Vivo
Source: Public Library of Science (PLoS)
Protective Effects of Ticagrelor on Myocardial Injury After Infarction
Source: Ovid Technologies (Wolters Kluwer Health)
Antiplatelet drugs and outcome in mixed admissions to an intensive care unit
Source: Ovid Technologies (Wolters Kluwer Health)
Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery.
Source: Elsevier BV
Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans
Source: American College of Cardiology Foundation. Published by Elsevier Inc.
Platelets and the innate immune system
Source: Wiley
C-reactive protein comes of age
Source: Springer Science and Business Media LLC
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention.
Source: Springer Science and Business Media LLC
Platelet P2Y12 Receptor Influences the Vessel Wall Response to Arterial Injury and Thrombosis
Source: Ovid Technologies (Wolters Kluwer Health)
Translational Implications of Platelets as Vascular First Responders.
Source: Ovid Technologies (Wolters Kluwer Health)
Novel approaches to P2Y12 inhibition and aspirin dosing.
Source: Informa UK Limited
Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critical ill patients?
Source: HAL CCSD
Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study.
Source: Informa UK Limited
Biology and pharmacology of the platelet P2Y12 receptor.
Source: Bentham Science Publishers Ltd.
Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial
Source: Elsevier BV

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.